Godavari Biorefineries Limited has informed the Exchange regarding a press release dated August 07, 2025, titled "Press Relase for Unaudited Financial Results of Q1FY 26".
GODAVARIB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Godavari Biorefineries posted Q1 FY26 results with total income of Rs. 534.0 Cr, up slightly from Rs. 525.3 Cr in Q1 FY25. The company swung to a positive EBITDA of Rs. 6.5 Cr from a loss of Rs. 9.5 Cr last year, though margins remained thin at 1.2%. Net loss narrowed to Rs. 16.0 Cr from Rs. 26.1 Cr. The Bio-Based Chemicals segment grew 43% YoY in EBITDA to Rs. 12.5 Cr. Ethanol production surged nearly 3x to 26,082 KL, supported by the return of B-heavy molasses-based ethanol. The company also highlighted progress in drug discovery, including European and Chinese patents for novel anti-cancer molecules.
The turnaround in EBITDA and narrowed losses suggest improving operations, but the company remains in the red with weak margins due to seasonal weakness. The strong growth in bio-based chemicals and ethanol volumes is positive, while the drug discovery patents add a long-term optionality, though near-term stock reaction may be muted given the continued quarterly loss.